Cargando…
Newborn Screening for Mucopolysaccharidosis Type II in Illinois: An Update
Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is a rare, progressive multisystemic lysosomal storage disorder with significant morbidity and premature mortality. Infants with MPS II develop signs and symptoms of the disorder in the early years of life, yet diagnostic delays are very common...
Autores principales: | Burton, Barbara K., Hickey, Rachel, Hitchins, Lauren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569764/ https://www.ncbi.nlm.nih.gov/pubmed/33117908 http://dx.doi.org/10.3390/ijns6030073 |
Ejemplares similares
-
Newborn Screening for X-Linked Adrenoleukodystrophy: The Initial Illinois Experience
por: Burton, Barbara K., et al.
Publicado: (2022) -
Newborn Screening for Pompe Disease in Illinois: Experience with 684,290 Infants
por: Burton, Barbara K., et al.
Publicado: (2020) -
Harmonization of Newborn Screening Results for Pompe Disease and Mucopolysaccharidosis Type I
por: Dorley, M. Christine, et al.
Publicado: (2023) -
Validation and Implementation of a Highly Sensitive and Efficient Newborn Screening Assay for Mucopolysaccharidosis Type II
por: Bilyeu, Heather, et al.
Publicado: (2020) -
Improved Reagents for Newborn Screening of Mucopolysaccharidosis
Types I, II, and VI by Tandem Mass Spectrometry
por: Chennamaneni, Naveen Kumar, et al.
Publicado: (2014)